PureTech

The rounds this investor is named on, who it invests beside, and where it shows up.

Named on one round in the feed.

Since 2026-07-02

ROUNDS

joined, none as lead

ROUNDS JOINED · USD

$180M

across 1 round

LATEST ROUND

Funding round · $180M · 2026-07-02

CO-INVESTORS

named beside it

Rounds

[ 1 ]

The rounds this investor is named on, who it invests beside, and where it shows up.

Company	Round	Amount	Announced	Role
Celea Therapeutics Celeatx offers investigational medications, particularly deupirfenidone, for the treatment of idiopathic pulmonary fibrosis (IPF).	Funding round Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it.	$180M	2026-07-02	[ PART ]